These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 29265398)

  • 21. Innovation Incentives and Biomarkers.
    Stern AD; Alexander BM; Chandra A
    Clin Pharmacol Ther; 2018 Jan; 103(1):34-36. PubMed ID: 29034452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory science and the role of the regulator in biomedical innovation.
    Honig PK; Huang SM
    Clin Pharmacol Ther; 2012 Mar; 91(3):347-52. PubMed ID: 22343804
    [No Abstract]   [Full Text] [Related]  

  • 23. Biomarkers for smoking cessation.
    Bough KJ; Lerman C; Rose JE; McClernon FJ; Kenny PJ; Tyndale RF; David SP; Stein EA; Uhl GR; Conti DV; Green C; Amur S
    Clin Pharmacol Ther; 2013 Jun; 93(6):526-38. PubMed ID: 23588313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective.
    Parasrampuria DA; Bandekar R; Puchalski TA
    Drug Discov Today; 2020 Oct; 25(10):1855-1864. PubMed ID: 32693162
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Key opinion leaders - a critical perspective.
    Scher JU; Schett G
    Nat Rev Rheumatol; 2021 Feb; 17(2):119-124. PubMed ID: 33257869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Big Data Transforms Discovery-Utilization Therapeutics Continuum.
    Waldman SA; Terzic A
    Clin Pharmacol Ther; 2016 Mar; 99(3):250-4. PubMed ID: 26888297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug regulatory systems must foster innovation.
    Schellekens H; Moors E; Leufkens HG
    Science; 2011 Apr; 332(6026):174-5. PubMed ID: 21474737
    [No Abstract]   [Full Text] [Related]  

  • 28. What matters in Cardiovascular Research? Scientific discovery driving clinical delivery.
    Guzik TJ; Antoniades C; Baker AH; Harrison DG; Loughrey CM; Maffia P; Murphy E; Nicklin SA; Peter K; Pearson J; Casadei B
    Cardiovasc Res; 2018 Oct; 114(12):1565-1568. PubMed ID: 30629152
    [No Abstract]   [Full Text] [Related]  

  • 29. Discovery in clinical and translational medicine.
    Wang DC; Wang X
    Clin Transl Med; 2021 Oct; 11(10):e568. PubMed ID: 34709762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why the drug development pipeline is not delivering better medicines.
    Naci H; Carter AW; Mossialos E
    BMJ; 2015 Oct; 351():h5542. PubMed ID: 26496934
    [No Abstract]   [Full Text] [Related]  

  • 31. Connecting Communities through a Translational Focus.
    Hamilton S
    Cell Rep Med; 2020 Apr; 1(1):100008. PubMed ID: 32572396
    [No Abstract]   [Full Text] [Related]  

  • 32. Translational Informatics Connects Real-World Information to Knowledge in an Increasingly Data-Driven World.
    McDonough CW; Breitenstein MK; Shahin M; Empey PE; Freimuth RR; Li L; Liebman M; Tuteja S
    Clin Pharmacol Ther; 2020 Apr; 107(4):738-741. PubMed ID: 31837229
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug discovery in a multidimensional world: systems, patterns, and networks.
    Dudley JT; Schadt E; Sirota M; Butte AJ; Ashley E
    J Cardiovasc Transl Res; 2010 Oct; 3(5):438-47. PubMed ID: 20677029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The utility of modeling and simulation in drug development and regulatory review.
    Huang SM; Abernethy DR; Wang Y; Zhao P; Zineh I
    J Pharm Sci; 2013 Sep; 102(9):2912-23. PubMed ID: 23712632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National Institutes of Health approaches to dissemination and implementation science: current and future directions.
    Glasgow RE; Vinson C; Chambers D; Khoury MJ; Kaplan RM; Hunter C
    Am J Public Health; 2012 Jul; 102(7):1274-81. PubMed ID: 22594758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valley of death: A proposal to build a "translational bridge" for the next generation.
    Gamo NJ; Birknow MR; Sullivan D; Kondo MA; Horiuchi Y; Sakurai T; Slusher BS; Sawa A
    Neurosci Res; 2017 Feb; 115():1-4. PubMed ID: 27876581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modeling technology innovation: how science, engineering, and industry methods can combine to generate beneficial socioeconomic impacts.
    Stone VI; Lane JP
    Implement Sci; 2012 May; 7():44. PubMed ID: 22591638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of a Dynamic Map for Learning, Communicating, Navigating, and Improving Therapeutic Development.
    Wagner JA; Dahlem AM; Hudson LD; Terry SF; Altman RB; Gilliland CT; DeFeo C; Austin CP
    Clin Transl Sci; 2018 Mar; 11(2):166-174. PubMed ID: 29271559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of public-private partnerships in addressing the biomedical innovation challenge.
    Said M; Zerhouni E
    Nat Rev Drug Discov; 2014 Nov; 13(11):789-90. PubMed ID: 25359362
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.
    Nattel S; Sager PT; Hüser J; Heijman J; Dobrev D
    Cardiovasc Res; 2021 Jun; 117(7):1616-1631. PubMed ID: 33769493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.